At a glance
- Originator Nonindustrial source
- Class Antidepressants; Nootropics
- Mechanism of Action Monoamine oxidase A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 18 Dec 2000 No-Development-Reported for Depression in Russia (Unknown route)
- 25 Feb 1998 Investigation in Depression in Russia (Unknown route)
- 09 Jan 1997 Preclinical development for Depression in Russia (Unknown route)